The Cannabis Observer

Half-Year and Full-Year Financial Roundup: Elixinol, Emyria, Epsilon, Avecho, Creso Pharma, AusCann, MGC Pharma, Botanix, Zelira

The Cannabis Observer ·
Half-Year and Full-Year Financial Roundup: Elixinol, Emyria, Epsilon, Avecho, Creso Pharma, AusCann, MGC Pharma, Botanix, Zelira

Elixinol Wellness reported a 2022 year-end loss of A$10.5m, a 38% improvement on the previous year, […]

FOUNDING MEMBERS

First 100 readers lock in 50% off for life

Sector coverage written for operators, not tourists. Reserve founding-member pricing before launch.

  • Weekday briefings on regulation, access schemes, and the companies shaping the market
  • Full archive and weekly deep-dives once premium goes live
  • 50% off the launch price, locked in for as long as your subscription stays active

Join 87 readers already on the waitlist

AusCann Avecho Botanix Pharmaceuticals Creso Pharma Elixinol Wellness Emerald Clinics Emyria Epsilon Healthcare Eurocann Health House International Hemp Foods in Australia MGC Pharmaceuticals Roby Zomer Sierra Sage Herbs Tod McGrouther William Lay Zerila Therapeutics

Related Articles